The store will not work correctly when cookies are disabled.
6-(6-(2-Fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-c]pyridin-1-yl)pyridin-2-amine
ID: ALA4784231
PubChem CID: 162666036
Max Phase: Preclinical
Molecular Formula: C18H14FN5O
Molecular Weight: 335.34
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(F)c1-c1cc2c(cn1)cnn2-c1cccc(N)n1
Standard InChI: InChI=1S/C18H14FN5O/c1-25-15-5-2-4-12(19)18(15)13-8-14-11(9-21-13)10-22-24(14)17-7-3-6-16(20)23-17/h2-10H,1H3,(H2,20,23)
Standard InChI Key: COEYBYRZCBPFHU-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
3.8140 -5.2609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8129 -6.0880 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5275 -6.5008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5257 -4.8482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2409 -5.2573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2457 -6.0834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0330 -6.3341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5147 -5.6629 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0251 -4.9974 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2754 -4.2115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0997 -4.8486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1029 -4.0230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3895 -3.6109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6743 -4.0235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8181 -3.6121 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3912 -5.2608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6736 -4.8554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8198 -2.7873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3965 -6.0856 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.0829 -4.0401 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3333 -3.2551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7776 -2.6445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9683 -2.8242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7217 -3.6090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1391 -3.0793 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
9 10 1 0
1 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 17 1 0
16 11 1 0
12 15 1 0
16 17 2 0
15 18 1 0
16 19 1 0
10 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 10 1 0
21 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 335.34 | Molecular Weight (Monoisotopic): 335.1182 | AlogP: 3.21 | #Rotatable Bonds: 3 |
Polar Surface Area: 78.85 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.06 | CX LogP: 3.02 | CX LogD: 3.02 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.62 | Np Likeness Score: -1.22 |
References
1. Yu EC,Methot JL,Fradera X,Lesburg CA,Lacey BM,Siliphaivanh P,Liu P,Smith DM,Xu Z,Piesvaux JA,Kawamura S,Xu H,Miller JR,Bittinger M,Pasternak A. (2021) Identification of Potent Reverse Indazole Inhibitors for HPK1., 12 (3.0): [PMID:33738073] [10.1021/acsmedchemlett.0c00672] |